| Literature DB >> 35887745 |
Samhati Mondal1, Nauder Faraday2, Wei Dong Gao2, Sarabdeep Singh3, Sachidanand Hebbar2, Kimberly N Hollander1, Thomas S Metkus4, Lee A Goeddel2, Maria Bauer2, Brian Bush2, Brian Cho2, Stephanie Cha2, Stephanie O Ibekwe5, Domagoj Mladinov6, Noah S Rolleri7, Laeben Lester2, Jochen Steppan2, Rosanne Sheinberg2, Nadia B Hensley2, Anubhav Kapoor8, Jeffrey M Dodd-O2.
Abstract
(1) Importance: Abnormal left ventricular (LV) diastolic function, with or without a diagnosis of heart failure, is a common finding that can be easily diagnosed by intra-operative transesophageal echocardiography (TEE). The association of diastolic function with duration of hospital stay after coronary artery bypass (CAB) is unknown. (2) Objective: To determine if selected TEE parameters of diastolic dysfunction are associated with length of hospital stay after coronary artery bypass surgery (CAB). (3) Design: Prospective observational study. (4) Setting: A single tertiary academic medical center. (5) Participants: Patients with normal systolic function undergoing isolated CAB from September 2017 through June 2018. (6) Exposures: LV function during diastole, as assessed by intra-operative TEE prior to coronary revascularization. (7) Main Outcomes and Measures: The primary outcome was duration of postoperative hospital stay. Secondary intermediate outcomes included common postoperative cardiac, respiratory, and renal complications. (8)Entities:
Keywords: coronary artery bypass; diastolic dysfunction; echocardiographic; heart failure; nonsystolic; perioperative; transesophageal echocardiography
Year: 2022 PMID: 35887745 PMCID: PMC9319456 DOI: 10.3390/jcm11143980
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Characteristics of study sample for subjects with abnormal and normal pre-surgical performance during diastole.
| Abnormal | Normal | ||
|---|---|---|---|
| Age, yrs (SD) | 67.5 ± 9.02 | 61.6 ± 8.5 | <0.001 *** |
| Gender Female, | 36 (34.2%) | 11 (15.4%) | 0.009 ** |
| Race, N (%) White/Balck/Asian/others | 80 (76%)/12 (11.5%)/ | 54 (76%)/9 (12.8%)/ | 0.86 |
| Congestive Heart Failure, N (%) | 21 (20%) | 4 (5.6%) | 0.01 * |
| Valvular Disease, N (%) | 28 (26.6%) | 8 (11.2%) | 0.02 * |
| Peripheral vascular | 15 (14.2%) | 5 (7.0%) | 0.21 |
| Hypertension, N (%) | 49 (46.6%) | 52 (73.2%) | <0.001 *** |
| Diabetes mellitus, N (%) | 40 (38%) | 30 (42%) | 0.69 |
| Chronic lung disease | 25 (23.8%) | 8 (11%) | 0.06 |
| Chronic kidney disease | 27 (25.7%) | 7 (9.8%) | 0.01 * |
| Obesity, N (%) | 33 (31.4%) | 22 (31%) | 0.99 |
| Myocardial infarction, N (%) | 29 (27.6%) | 10 (14.0%) | 0.052 * |
| Stroke/TIA, N (%) | 7 (6.6%) | 4 (5.6%) | 0.99 |
| Arrhythmia, N (%) | 26 (24.7%) | 11 (15.4%) | 0.16 |
| ASA class = 4, N (%) | 55 (52.3%) | 23 (32.3%) | 0.01 * |
| Duration of CPB CPB | 96.33 ± 37.5 | 108.0 ± 49.09 | 0.09 * |
| Latent Class 2-High | 48 (45.7%) | 12 (17%) | <0.001 *** |
*—statistically significant; **—statistically very significant, ***—statistically extremely significant.
Figure 1Cox proportional hazard model for daily probability of discharge vs. time (days) following surgery. Subjects with abnormal (blue) vs. normal (red) left ventricular performance during diastole.
Figure 2Dose–response relationship between severity of performance abnormality during diastole and daily probability of discharge; mild dysfunction (green), moderate dysfunction (blue), severe dysfunction (purple), normal (red). Survival analyses performed using R programming environment. Estimates and CIs obtained using the “coxph” function. Lower (RR 0.54/95% CI 0.40–0.75) for those with diastolic dysfunction compared to those with normal performance during diastole in unadjusted analysis.
Adjusted and un-adjusted rate ratios for discharge from the hospital using cox proportional hazard model.
| Un-Adjusted Rate Ratios | Adjusted Rate Ratios Model 1 | Adjusted Rate Ratios Model 2 | Adjusted Rate Ratios Model 3 | |||||
|---|---|---|---|---|---|---|---|---|
| Abnormal pre-surgical performance during diastole | 0.54 *** (0.40,0.74) | <0.001 | 0.52 *** (0.36,0.75) | <0.0001 | 0.56 ** | 0.001 | 0.61 ** (0.42, 0.88) | 0.009 |
| E; ref = normal | 0.62 * (0.41, 0.94) | 0.023 | 0.57 * (0.37, 0.88) | 0.01 | 0.58 * (0.38, 0.88) | 0.01 | 0.61 * (0.39, 0.94) | 0.02 |
| E-e′ ratio; ref = normal | 0.57 * (0.33, 0.97) | 0.04 | 0.78 (0.43, 1.42) | 0.42 | 0.82 (0.46, 1.44) | 0.49 | 0.85 (0.48, 1.52) | 0.60 |
| Duration of CPB | 0.99 (0.99, 1.00) | 0.61 | 0.997 (0.993, 1.00) | 0.17 | 0.997 | 0.12 | 0.996 * (0.992, 0.999) | 0.044 |
| Age | 0.98 (0.97, 1.00) | 0.08 | 0.993 (0.97, 1.01) | 0.46 | ||||
| Female gender | 1.46 * (1.03,2.07) | 0.03 | 1.05 (0.70,1.57) | 0.80 | ||||
| CHF | 0.43 *** (0.26, 0.71) | 0.001 | 0.50 * (0.25, 0.99) | 0.047 | ||||
| Valvular disease | 0.70 (0.47, 1.03) | 0.07 | ||||||
| Hypertension | 1.67 *** (1.22, 2.29) | 0.001 | 1.14 (0.67, 1.92) | 0.62 | ||||
| Chronic Lung disease | 0.97 (0.66, 1.42) | 0.88 | ||||||
| Renal disease | 0.58 *** (0.40, 0.85) | 0.006 | 0.55 * (0.30, 0.99) | 0.049 | ||||
| Myocardial infarction | 0.55 *** (0.38, 0.79) | 0.001 | 0.51 *** (0.35, 0.75) | <0.001 | ||||
| ASA = 4 | 0.75 (0.55, 1.02) | 0.06 | ||||||
| Latent class 2-high severity of illness | 0.56 *** (0.40, 0.78) | <0.001 | 0.65 * | 0.02 | 1.20 (0.56, 2.55) | 0.63 |
*—statistically significant; **—statistically very significant, ***—statistically extremely significant.
Figure 3Probability of discharge over time in days by interaction between pre-surgical performance during diastole (normal/abnormal) and latent class (low/high severity) using the Cox proportional hazard model.
Secondary outcomes for subjects with abnormal and normal pre-surgical performance based on selected parameters during diastole.
| Abnormal | Normal | ||
|---|---|---|---|
| Interval to extubation | 45 (42.8%) | 17 (23.9%) | 0.01 * |
| Interval to breathing from room air, days, median (IQR) | 1.63 (0.68, 3.04) | 0.89 (0.55, 2.82) | 0.05 (Kruskal–Wallis) |
| Composite | 21 (20%) | 6 (8.4%) | 0.037 |
| Atrial fibrillation, N (%) | 30 (28.5%) | 14 (19.7%) | 0.26 |
| Hypotension, N (%) | 47 (44%) | 23 (32%) | 0.13 |
| Hypervolemia, N (%) | 48 (46%) | 34 (49%) | 0.89 |
| Maximum increase in creatinine, %, SD | 18 ± 27 | 14 ± 15 | 0.21 |
| KDIGO AKI, N (%) | 26 (24.7%) | 18 (25.3%) | 0.99 |
| Ischemic stroke, N (%) | 0 (0%) | 2 (2.8%) | 0.16 |
| Composite Infectious morbidity | 6 (5.7%)) | 1 (1.4%) | 0.23 |
| ICU readmission, N (%) | 8 (7.6%) | 1 (1.4%) | 0.08 |
Composite infectious morbidity = SSI, pneumonia, sepsis; Composite cardiopulmonary morbidity = heart failure, resp failure, resp insufficiency, pulm edema. *—statistically significant.
Relation of baseline abnormal nonsystolic function and secondary outcomes to time to hospital discharge.
| Un-Adjusted Rate Ratios | Adjusted Rate | |||
|---|---|---|---|---|
| Dysfunction before | 0.54 *** (0.40, 0.75) | <0.001 | 0.63 * (0.45, 0.89) | 0.01 |
| Latent class 2-high | 0.53 *** (0.38, 0.74) | <0.001 | 0.73 (0.50, 1.07) | 0.11 |
| Duration of CPB | 0.99 (0.99, 1.00) | 0.70 | 0.997 (0.992, 1.001) | 0.16 |
| Interval to extubation >6 | 0.60 ** (0.44, 0.83) | 0.002 | 0.81 (0.57, 1.15) | 0.25 |
| Time to room air | 0.88 *** (0.81, 0.94) | <0.001 | 0.93 (0.86, 1.00) | 0.08 |
| Composite cardiopulmonary morbidity | 0.47 *** (0.31, 0.73) | <0.001 | 0.78 (0.47, 1.30) | 0.34 |
| Atrial fibrillation | 0.70 * (0.49, 0.99) | 0.04 | 0.87 (0.60, 1.26) | 0.49 |
| Hypotension | 0.61 ** (0.44, 0.83) | 0.001 | 0.73 (0.52, 1.01) | 0.06 |
| Composite Infectious morbidity | 0.30 ** (0.13, 0.70) | 0.005 | 0.30 * (0.12, 0.77) | 0.01 |
| ICU Readmission | 0.46 * (0.23, 0.90) | 0.02 | 0.60 (0.29, 1.26) | 0.18 |
Composite infectious morbidity = SSI, pneumonia, sepsis; Composite cardiopulmonary morbidity= heart failure, resp failure, resp insufficiency, pulm edema. *—statistically significant; **—statistically very significant, ***—statistically extremely significant.